Literature DB >> 22219592

Impact of liver diseases on the development of type 2 diabetes mellitus.

Po-Shiuan Hsieh, Yen-Ju Hsieh.   

Abstract

The prevalence of type 2 diabetes mellitus (T2DM) is higher in patients who have liver diseases such as nonalcoholic fatty liver disease, chronic viral hepatitis, hemochromatosis, alcoholic liver disease and cirrhosis. It is suggested that there is a pathogenic link between the presence of T2DM and the severity of liver injury. However, evidence related to the impact of hepatic inflammation on the development of T2DM has not yet emerged. This article provides an overview of the evidence for an increased prevalence of diabetes in a range of liver diseases, the impact of liver diseases on insulin resistance and β cell dysfunction, and the potential mechanisms whereby coexistent liver diseases exacerbate the development of T2DM.

Entities:  

Keywords:  Hepatic inflammation; Insulin resistance; Type 2 diabetes mellitus; β cell dysfunction

Mesh:

Substances:

Year:  2011        PMID: 22219592      PMCID: PMC3247687          DOI: 10.3748/wjg.v17.i48.5240

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  56 in total

Review 1.  Nonalcoholic steatohepatitis: what we know in the new millennium.

Authors:  Stephen A Harrison; Shailesh Kadakia; Kevin A Lang; Steven Schenker
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

2.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

Authors:  N N Zein; A S Abdulkarim; R H Wiesner; K S Egan; D H Persing
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

3.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Authors:  Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

4.  Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.

Authors:  Hilla Knobler; Taiba Zhornicky; Alex Sandler; Nurit Haran; Yafa Ashur; Ami Schattner
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

5.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

Authors:  Anneli Seppälä-Lindroos; Satu Vehkavaara; Anna-Maija Häkkinen; Takashi Goto; Jukka Westerbacka; Anssi Sovijärvi; Juha Halavaara; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

6.  Clinical implications of hepatogenous diabetes in liver cirrhosis.

Authors:  Andreas Holstein; S Hinze; E Thiessen; A Plaschke; E-H Egberts
Journal:  J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 4.029

7.  Identification and characterization of metabolically benign obesity in humans.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Kilian Rittig; Bernd Balletshofer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Arch Intern Med       Date:  2008-08-11

8.  Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

Authors:  Jason M Hui; Archana Sud; Geoffrey C Farrell; Priyanka Bandara; Karen Byth; James G Kench; Geoffrey W McCaughan; Jacob George
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

9.  Hepatitis C virus infection and incident type 2 diabetes.

Authors:  Shruti H Mehta; Frederick L Brancati; Steffanie A Strathdee; James S Pankow; Dale Netski; Josef Coresh; Moyses Szklo; David L Thomas
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

10.  Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

Authors:  Yoshizumi Shintani; Hajime Fujie; Hideyuki Miyoshi; Takeya Tsutsumi; Kazuhisa Tsukamoto; Satoshi Kimura; Kyoji Moriya; Kazuhiko Koike
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  15 in total

Review 1.  What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

2.  New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.

Authors:  Shintaro Yagi; Toshimi Kaido; Taku Iida; Atsushi Yoshizawa; Hideaki Okajima; Shinji Uemoto
Journal:  Surg Today       Date:  2016-11-11       Impact factor: 2.549

3.  Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.

Authors:  Chang-Hai Liu; Wei Jiang; Dong-Bo Wu; Qing-Min Zeng; You-Juan Wang; Hong Tang
Journal:  Dig Dis Sci       Date:  2022-10-13       Impact factor: 3.487

Review 4.  An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

Authors:  Pankaj Puri; Narendra Kotwal
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 5.  Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

Review 6.  Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature.

Authors:  Carlo B Giorda; Elisa Nada; Barbara Tartaglino
Journal:  Endocrine       Date:  2014-02-08       Impact factor: 3.633

7.  Anti-oxidative role of quercetin derived from Allium cepa on aldehyde oxidase (OX-LDL) and hepatocytes apoptosis in streptozotocin-induced diabetic rat.

Authors:  Mina Bakhshaeshi; Arash Khaki; Fatemeh Fathiazad; Amir Afshin Khaki; Elham Ghadamkheir
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

Review 8.  Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.

Authors:  Zobair Younossi; Katrin Kochems; Marc de Ridder; Desmond Curran; Eveline M Bunge; Laurence de Moerlooze
Journal:  Hum Vaccin Immunother       Date:  2017-07-25       Impact factor: 3.452

9.  Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study.

Authors:  Muhammad Sadik Memon; Zain Islam Arain; Farukh Naz; Madiha Zaki; Suresh Kumar; Asif Ali Burney
Journal:  J Diabetes Res       Date:  2013-08-01       Impact factor: 4.011

10.  Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study.

Authors:  Ping-Hsin Hsieh; Jing-Yang Huang; Oswald Ndi Nfor; Chia-Chi Lung; Chien-Chang Ho; Yung-Po Liaw
Journal:  Oncotarget       Date:  2017-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.